James Reed

Partner

Bristol

James Reed is a partner specialising in domestic and cross border M&A, joint ventures and other corporate and commercial arrangements. James is a member of the DACB LLP Group Board.

Successfully added
Failed to add

About James

Bio
  • Biography

    James has extensive experience in advising major corporates and has spent time practising in Sydney, Australia and Abu Dhabi, United Arab Emirates.

    He leads the corporate and commercial team in our Bristol office and has a particular focus on the healthcare sector.

    Relevant experience includes advising:

    • Elysium Healthcare in relation to its acquisition of London Care Partnerships, consisting of nine learning disability facilities across south west London.
    • HCA International Limited in relation to its acquisition of a majority interest in Hathor Chelsea Limited, operator of the Lister Fertility Clinic and the Lister Hospital in London.
    • SunEdison in relation to 10+ acquisitions of shares in companies owning rights to develop utility scale solar parks in the UK.
    • McAfee Inc across 11 countries in relation to a restructuring project following its US$389 million acquisition of the Stonesoft Group.
Sector Expertise
  • Financial Services

  • Health and Social Care

  • Infrastructure and Projects

Service Expertise
  • Corporate

  • Mergers and Acquisitions

Office Location

Bristol Skyline

Bristol

  • DAC Beachcroft LLP
  • Portwall Place, Portwall Lane
  • Bristol, BS1 6NA

+44 (0) 117 918 2000

View our office

Articles

There are no matching articles, please try a different filter.

DAC Beachcroft bolsters its tax practice with partner hire

News

1 min read

DAC Beachcroft bolsters its tax practice with partner hire

DAC Beachcroft partners with ABHI to boost UK healthtech companies in the US

News

1 min read

DAC Beachcroft partners with ABHI to boost UK healthtech companies in the US

M&A: Healthcare transformation drives dealmaking resurgence

Health and Social Care

10 Min Read

M&A: Healthcare transformation drives dealmaking resurgence